AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
QuinStreet: Lake Street lowers PT to $18 from $19, maintains Hold rating.
ByAinvest
Friday, Aug 8, 2025 6:31 pm ET1min read
QuinStreet: Lake Street lowers PT to $18 from $19, maintains Hold rating.
Lake Street Capital Markets has revised its price target for Sight Sciences Inc. (NASDAQ:SGHT) from $19 to $18, while maintaining its Hold rating. The adjustment comes following the company's second-quarter 2025 financial results, which exceeded market expectations.Sight Sciences reported $19.6 million in revenue for the quarter, surpassing the forecasted $18.18 million. The company also posted a narrower-than-expected loss per share of $0.23, compared to the anticipated loss of $0.26. These results marked a positive earnings surprise for Sight Sciences.
The stock experienced a decline in after-hours trading, aligning with broader market trends. Despite the strong financial performance, the company's stock has shown resilience, gaining over 8.5% in the past week and trading at $4.13, according to InvestingPro data.
Lake Street cited several factors supporting the company's strong performance, including stabilization in its Surgical glaucoma business, prudently set guidance, improved gross margins, and potential catalysts from Dry eye contract wins. The investment firm noted that Sight Sciences shares currently offer "an attractive risk/reward" ratio, trading at approximately 1.7 times the expected 2025 enterprise value to sales.
Sight Sciences specializes in medical devices for ophthalmology, with products targeting glaucoma and dry eye disease treatment. The company maintains a strong financial position with a current ratio of 10.47, indicating robust liquidity, and holds more cash than debt on its balance sheet.
References:
[1] https://uk.investing.com/news/analyst-ratings/sight-sciences-stock-rating-upgraded-by-lake-street-on-stabilizing-business-93CH-4211167
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet